Cargando…

Concomitant Use of Direct Oral Anticoagulants and Antiepileptic Drugs: A Prospective Cohort Study in Patients with Atrial Fibrillation

BACKGROUND: European guidelines do not recommend the use of carbamazepine, levetiracetam, phenobarbital, phenytoin, topiramate and valproic acid in patients taking direct oral anticoagulants (DOACs). Little is known regarding the clinical relevance of the interaction between DOACs and antiepileptic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giustozzi, Michela, Mazzetti, Matteo, Paciaroni, Maurizio, Agnelli, Giancarlo, Becattini, Cecilia, Vedovati, Maria Cristina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815539/ https://www.ncbi.nlm.nih.gov/pubmed/33284370 http://dx.doi.org/10.1007/s40261-020-00982-8

Ejemplares similares

Data on the use of oral anticoagulants in nonagenarians with atrial fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2019)

Rates and Determinants for the Use of Anticoagulation Treatment before Stroke in Patients with Known Atrial Fibrillation
por: Giustozzi, Michela, et al.
Publicado: (2020)

Direct Oral Anticoagulants in Old and Frail Patients with Atrial Fibrillation: The Advantages of an Anticoagulation Service
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

Type 2 Valvular Heart Disease Affects Decision Making for Anticoagulation in Patients with Atrial Fibrillation: The UMBRIA-Fibrillazione Atriale Prospective Study
por: Vedovati, Maria Cristina, et al.
Publicado: (2019)

Venous thromboembolism and COVID-19: Mind the gap between clinical epidemiology and patient management
por: Giustozzi, Michela, et al.
Publicado: (2020)

ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis
por: Giustozzi, Michela, et al.
Publicado: (2022)

Concomitant Use of Diltiazem With Direct Oral Anticoagulants and Bleeding Risk in Atrial Fibrillation
por: Xu, Yunwen, et al.
Publicado: (2022)

Shock and Diffuse ST-elevation in a Patient with Coronavirus Disease-2019 Disease
por: Vedovati, Maria Cristina, et al.
Publicado: (2020)

DOACs in patients with brain cancers: promising but still a long way to go
por: Giustozzi, Michela, et al.
Publicado: (2022)

Concomitant use of direct oral anticoagulants and aspirin versus direct oral anticoagulants alone in atrial fibrillation and flutter: a retrospective cohort
por: Said, Ahmad, et al.
Publicado: (2020)

Efficacy and safety of two heparin regimens for prevention of venous thromboembolism in hospitalized patients with COVID-19: a meta-analysis
por: Vedovati, Maria Cristina, et al.
Publicado: (2022)

The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation
por: van den Dries, Carline J., et al.
Publicado: (2020)

New anticoagulants for the prevention of venous thromboembolism
por: Becattini, Cecilia, et al.
Publicado: (2010)

Atrial Fibrillation, Oral Anticoagulants, and Concomitant Active Cancer: Benefits and Risks
por: Atterman, Adriano, et al.
Publicado: (2021)

Use of Oral Anticoagulants in Patients with Atrial Fibrillation: Preliminary Data from the Italian Atrial Fibrillation (ITALY-AF) Registry
por: Angeli, Fabio, et al.
Publicado: (2023)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Direct oral anticoagulants versus vitamin K antagonists after recent ischemic stroke in patients with atrial fibrillation
por: Seiffge, David J., et al.
Publicado: (2019)

Concomitant diabetes with atrial fibrillation and anticoagulation management considerations
por: Kreutz, Reinhold, et al.
Publicado: (2020)

Type 2 Diabetes, Atrial Fibrillation, and Direct Oral Anticoagulation
por: Prídavková, Dana, et al.
Publicado: (2019)

Direct Oral Anticoagulants in Patients With Cancer and Nonvalvular Atrial Fibrillation
por: Davis, Margot K., et al.
Publicado: (2021)

Characterization of patients with atrial fibrillation not treated with oral anticoagulants
por: Johansson, Cecilia, et al.
Publicado: (2014)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Prevalence of oral anticoagulation in atrial fibrillation
por: Bartholomay, Eduardo, et al.
Publicado: (2014)

Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation
por: Polymeris, Alexandros A., et al.
Publicado: (2021)

Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2018)

Management of Direct Oral Anticoagulants in Patients with Atrial Fibrillation Undergoing Cardioversion
por: Coppola, Giuseppe, et al.
Publicado: (2019)

Convenience and satisfaction in direct oral anticoagulant–treated patients with atrial fibrillation
por: Piersma‐Wichers, Margriet, et al.
Publicado: (2021)

Comparison of phenprocoumon with direct oral anticoagulants in catheter ablation of atrial fibrillation
por: Gjermeni, Diona, et al.
Publicado: (2023)

Ischemic Stroke despite Oral Anticoagulant Therapy in Patients with Atrial Fibrillation
por: Seiffge, David J., et al.
Publicado: (2020)

Veterans Perceptions of Satisfaction and Convenience with Anticoagulants for Atrial Fibrillation: Warfarin versus Direct Oral Anticoagulants
por: Mull, Hillary J, et al.
Publicado: (2020)

Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance
por: Vio, Riccardo, et al.
Publicado: (2021)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Choice of Oral Anticoagulant: Outcomes in Atrial Fibrillation Patients Post-Stroke Despite Direct Oral Anticoagulant Use
por: Duong, Eric, et al.
Publicado: (2023)

Direct oral anticoagulants versus standard triple therapy in atrial fibrillation and PCI: meta-analysis
por: Brunetti, Natale Daniele, et al.
Publicado: (2018)

Corrigendum: Pharmacokinetic Interactions of Clinical Interest Between Direct Oral Anticoagulants and Antiepileptic Drugs
por: Galgani, Alessandro, et al.
Publicado: (2020)

How to choose appropriate direct oral anticoagulant for patient with nonvalvular atrial fibrillation
por: Schaefer, Jordan K., et al.
Publicado: (2015)

Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Valvular Heart Lesions
por: Di Biase, Luigi
Publicado: (2016)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
por: Jang, Soo Min, et al.
Publicado: (2020)

Direct Oral Anticoagulant Adherence of Patients With Atrial Fibrillation Transitioned from Warfarin
por: Pundi, Krishna N., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a0lad0ln2tj6d7946kmk2nkr58